Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Sarcoma 180 D012510 21 associated lipids
Edema D004487 152 associated lipids
Arthritis D001168 41 associated lipids
Heart Failure D006333 36 associated lipids
Pulmonary Edema D011654 23 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Acne Vulgaris D000152 35 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Son DJ et al. Enhanced release of sphingosine-1-phosphate from hypercholesterolemic platelets: role in development of hypercholesterolemic atherosclerosis. 2008 Prostaglandins Leukot. Essent. Fatty Acids pmid:18571912
Carpio LC et al. Sphingolipids stimulate cell growth via MAP kinase activation in osteoblastic cells. 1999 Prostaglandins Leukot. Essent. Fatty Acids pmid:10670688
Kozawa O et al. Sphingosine 1-phosphate amplifies phosphoinositide hydrolysis stimulated by prostaglandin f2 alpha in osteoblasts: involvement of p38MAP kinase. 2000 Prostaglandins Leukot. Essent. Fatty Acids pmid:10913228
Liu H et al. Sphingosine kinases: a novel family of lipid kinases. 2002 Prog. Nucleic Acid Res. Mol. Biol. pmid:12102559
Pyne S et al. Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances. 2016 Prog. Lipid Res. pmid:26970273
Gomez-Muñoz A et al. Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate. 2016 Prog. Lipid Res. pmid:26703189
Pyne NJ and Tigyi GJ A reflection of the lasting contributions from Dr. Robert Bittman to sterol trafficking, sphingolipid and phospholipid research. 2016 Prog. Lipid Res. pmid:26584871
Kihara A et al. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate. 2007 Prog. Lipid Res. pmid:17449104
Watterson K et al. Pleiotropic actions of sphingosine-1-phosphate. 2003 Prog. Lipid Res. pmid:12790117
Gangoiti P et al. Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease. 2010 Prog. Lipid Res. pmid:20193711
Nadal A et al. Glial cell responses to lipids bound to albumin in serum and plasma. 2001 Prog. Brain Res. pmid:11545003
Egom EE et al. Cardioprotection in ischemia/reperfusion injury: spotlight on sphingosine-1-phosphate and bradykinin signalling. 2010 Prog. Biophys. Mol. Biol. pmid:20080123
Mitra P et al. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. 2006 Proc. Natl. Acad. Sci. U.S.A. pmid:17050692
Cannon RE et al. Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22949658
Czarnota GJ et al. Tumor radiation response enhancement by acoustical stimulation of the vasculature. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22778441
Ito K et al. Integrin α9 on lymphatic endothelial cells regulates lymphocyte egress. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:24516133
Pederson L et al. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. 2008 Proc. Natl. Acad. Sci. U.S.A. pmid:19075223
Yanagida K et al. Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1. 2017 Proc. Natl. Acad. Sci. U.S.A. pmid:28396408
Park K et al. ER stress stimulates production of the key antimicrobial peptide, cathelicidin, by forming a previously unidentified intracellular S1P signaling complex. 2016 Proc. Natl. Acad. Sci. U.S.A. pmid:26903652
Mandala SM et al. Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1- phosphate and induces cell death. 2000 Proc. Natl. Acad. Sci. U.S.A. pmid:10859351
Browne CD et al. SHEP1 partners with CasL to promote marginal zone B-cell maturation. 2010 Proc. Natl. Acad. Sci. U.S.A. pmid:20956287
Mandala SM et al. Sphingoid base 1-phosphate phosphatase: a key regulator of sphingolipid metabolism and stress response. 1998 Proc. Natl. Acad. Sci. U.S.A. pmid:9419344
Xia P et al. Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. 1998 Proc. Natl. Acad. Sci. U.S.A. pmid:9826677
Bouma HR et al. Low body temperature governs the decline of circulating lymphocytes during hibernation through sphingosine-1-phosphate. 2011 Proc. Natl. Acad. Sci. U.S.A. pmid:21245336
Sadahira Y et al. Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness. 1992 Proc. Natl. Acad. Sci. U.S.A. pmid:1409683
Dusaban SS et al. Phospholipase C epsilon links G protein-coupled receptor activation to inflammatory astrocytic responses. 2013 Proc. Natl. Acad. Sci. U.S.A. pmid:23401561
Wojciak JM et al. The crystal structure of sphingosine-1-phosphate in complex with a Fab fragment reveals metal bridging of an antibody and its antigen. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19815502
Liu Z et al. Mechanical tugging force regulates the size of cell-cell junctions. 2010 Proc. Natl. Acad. Sci. U.S.A. pmid:20463286
Ledent C et al. Premature ovarian aging in mice deficient for Gpr3. 2005 Proc. Natl. Acad. Sci. U.S.A. pmid:15956199
Christoffersen C et al. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. 2011 Proc. Natl. Acad. Sci. U.S.A. pmid:21606363
Kikuta J et al. Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D. 2013 Proc. Natl. Acad. Sci. U.S.A. pmid:23569273
Nguyen DH et al. Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro. 2013 Proc. Natl. Acad. Sci. U.S.A. pmid:23569284
Roviezzo F et al. Human eosinophil chemotaxis and selective in vivo recruitment by sphingosine 1-phosphate. 2004 Proc. Natl. Acad. Sci. U.S.A. pmid:15254297
Matsushita K et al. Sphingosine 1-phosphate activates Weibel-Palade body exocytosis. 2004 Proc. Natl. Acad. Sci. U.S.A. pmid:15273282
Goetzl EJ et al. Lysophospholipid enhancement of human T cell sensitivity to diphtheria toxin by increased expression of heparin-binding epidermal growth factor. 1999 May-Jun Proc. Assoc. Am. Physicians pmid:10354366
Shea BS and Tager AM Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis. 2012 Proc Am Thorac Soc pmid:22802282
Kurek K et al. [The role of sphingolipids in selected cardiovascular diseases]. 2013 Postepy Hig Med Dosw (Online) pmid:24088546
Kurek K et al. [Role of sphingolipids in digestive system]. 2012 Postepy Hig Med Dosw (Online) pmid:23175343
Salata D et al. [Sphingosine-1-phosphate--molecular maestro]. 2012 Postepy Biochem. pmid:23373414
Wang X et al. Sphingosine 1-Phosphate Activation of EGFR As a Novel Target for Meningitic Escherichia coli Penetration of the Blood-Brain Barrier. 2016 PLoS Pathog. pmid:27711202
Abdel Hadi L et al. Sphingosine Kinase 2 and Ceramide Transport as Key Targets of the Natural Flavonoid Luteolin to Induce Apoptosis in Colon Cancer Cells. 2015 PLoS ONE pmid:26580959
Bot M et al. Hematopoietic sphingosine 1-phosphate lyase deficiency decreases atherosclerotic lesion development in LDL-receptor deficient mice. 2013 PLoS ONE pmid:23700419
Zhong Y et al. Nephrokeli, a Chinese herbal formula, may improve IgA nephropathy through regulation of the sphingosine-1-phosphate pathway. 2015 PLoS ONE pmid:25633986
Gomes L et al. Sphingosine 1-phosphate in acute dengue infection. 2014 PLoS ONE pmid:25409037
Beckham TH et al. Acid ceramidase promotes nuclear export of PTEN through sphingosine 1-phosphate mediated Akt signaling. 2013 PLoS ONE pmid:24098536
Kujjo LL et al. Chemotherapy-induced late transgenerational effects in mice. 2011 PLoS ONE pmid:21437292
Kondo S et al. Memo has a novel role in S1P signaling and is [corrected] crucial for vascular development. 2014 PLoS ONE pmid:24714781
Yasuo M et al. Fenretinide causes emphysema, which is prevented by sphingosine 1-phoshate. 2013 PLoS ONE pmid:23326540
Lim M et al. The role of sphingosine kinase 1/sphingosine-1-phosphate pathway in the myogenic tone of posterior cerebral arteries. 2012 PLoS ONE pmid:22532844
Jongsma M et al. LPA is a chemorepellent for B16 melanoma cells: action through the cAMP-elevating LPA5 receptor. 2011 PLoS ONE pmid:22195035